Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1451, 2004-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inhaled 2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease
Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. :
Access to resources
Recommend
Long-acting 2-adrenoceptor agonists: increased risk of death?
Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. :
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk
Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. :
Triptans: no increase in stroke or cardiovascular event risk
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :